Skip to main content

News

New study reveals breast cancer drug combination has impact on other cancers

4 Mar 2024
Lead author Professor Roisin Connolly, Director of Cancer Research @UCC
  • Drug commonly used to treat HER2-positive breast cancer sees tumour shrinkage in several other cancer types.  

  • Cancer treatment combination may have more uses than previously thought.

Cancer Research @UCC

4th floor, Western Gateway Building , Western Road, Cork

Top